User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 14 results.
    • Journal article
    (90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.
    Decaudin, Didier Mounier, Nicolas Tilly, Hervé Ribrag, Vincent Ghesquières, Hervé Bouabdallah, Krimo Morschhauser, Franck Coiffier, Bertrand Le Gouill, Steven Bologna, Serge Delarue, Richard Huynh, Anne Bosly, André[UCL] Brière, Josette Gisselbrecht, Christian (2011) Clinical lymphoma, myeloma & leukemia — Vol. 11, no. 2, p. 212-8 (2011)
    • Journal article
    Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study.
    Houot, Roch Cartron, Guillaume Bijou, Fontanet de Guibert, Sophie Salles, Gilles A Fruchart, Christophe Bouabdallah, Krimo Maerevoet, Marie Feugier, Pierre Le Gouill, Steven Tilly, Hervé Casasnovas, Rene-Olivier Moluçon-Chabrot, Cécile Van Den Neste, Eric[UCL] Zachee, Pierre André, Marc[UCL] Bonnet, Christophe Haioun, Corinne Van Hoof, Achiel Van Eygen, Koen Molina, Lysiane Nicolas-Virelizier, Emmanuelle Ruminy, Philippe Morschhauser, Franck (2019) Leukemia — Vol. 33, no. 3, p. 776-780 (2019)
    • Journal article
    Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA.
    Le Gouill, Steven Ghesquieres, Herve Obéric, Lucie Morschhauser, Franck Tilly, Herve Ribrag, Vincent Lamy, Thierry Thieblemont, Catherine Maisonneuve, Herve Gerard Gressin, Remy Bouabdallah, Krimo Haioun, Corinne Damaj, Gandhi Fornecker, Luc-Matthieu Bouabdallah, Reda Feugier, Pierre Sibon, David Cartron, Guillaume Bonnet, Christophe André, Marc[UCL] Chartier, Loic Ruminy, Philippe Kraeber-Bodere, F Bodet-Milin, C Berriolo-Riedinger, Alina Briere, Josette Jais, Jean-Philippe Molina, Thierry Itti, Emmanuel Casasnovas, Olivier (2021) Blood — Vol. 137, no. 17, p. 2307-2320 (2021)
    • Journal article
    Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    Le Gouill, Steven Thieblemont, Catherine Oberic, Lucie Moreau, Anne Bouabdallah, Krimo Dartigeas, Caroline Damaj, Gandhi Gastinne, Thomas Ribrag, Vincent Feugier, Pierre Casasnovas, Olivier Zerazhi, Hacène Haioun, Corinne Maisonneuve, Hervé Houot, Roch Jardin, Fabrice Van Den Neste, Eric[UCL] Tournilhac, Olivier Le Dû, Katell Morschhauser, Franck Cartron, Guillaume Fornecker, Luc-Matthieu Canioni, Danielle Callanan, Mary Béné, Marie C Salles, Gilles Tilly, Hervé Lamy, Thierry Gressin, Remy Hermine, Olivier LYSA Group Bosly, André[UCL] (2017) New England Journal of Medicine — Vol. 377, no.13, p. 1250-1260 (2017)
    • Journal article
    Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
    Thomas, José Fermé, Christophe Noordijk, Evert M Morschhauser, Franck Girinsky, Théodore Gaillard, Isabelle Lugtenburg, Pieternella J André, Marc[UCL] Lybeert, Marnix L M Stamatoullas, Aspasia Beijert, Max Hélias, Philippe Eghbali, Houchingue Gabarre, Jean van der Maazen, Richard W M Jaubert, Jérôme Bouabdallah, Krimo Boulat, Olivier Roesink, Judith M Christian, Bernard Ong, Francisca Bordessoule, Dominique Tertian, Gérard Gonzalez, Hugo Vranovsky, Andrej Quittet, Philippe Tirelli, Umberto de Jong, Daphne Audouin, Josée Aleman, Berthe M P Henry-Amar, Michel (2018) International Journal of Radiation: Oncology - Biology - Physics — Vol. 100, p. 1133-1145 (2018)
    • Journal article
    Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.
    Bonnet, Christophe Dupuis, Jehan Tilly, Hervé Lamy, Thierry Fruchart, Christophe le Gouill, Steven Thieblemont, Catherine Morschhauser, Franck Casasnovas, Olivier Bouabdallah, Krimo Ghesquieres, Hervé Van Den Neste, Eric[UCL] André, Marc[UCL] Cartron, Guillaume Salles, Gilles (2022) Cancers — Vol. 14, no. 7, p. 1761 [1-14] (2022)
    • Speech
    Autologous Stem cell Transplantation (ASCT) in CLL. Results of a Phase III Randomized Multicenter Trial
    Sutton, Laurent Van Den Neste, Eric[UCL] Chevret, Sylvie Maloum, Karina Toumilhac, Olivier Divine, Marine Leblond, Veronique Corront, Bernadette Lepretre, Stephane Eghbali, Houchingue Michallet, Mauricette Maloisel, Frederic Bouabdallah, Krimo Berthou, Christian Brice, Pauline Decaudin, Didier Gonzalez, Hugo Khac, Florence Nguyen Davi, Frederic Lejeune, Julie Merle-Beral, Helene Leporrier, Michel (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans (La)
    • Journal article
    PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
    Casasnovas, René-Olivier Bouabdallah, Reda Brice, Pauline Lazarovici, Julien Ghesquieres, Hervé Stamatoullas, Aspasia Dupuis, Jehan Gac, Anne-Claire Gastinne, Thomas Joly, Bertrand Bouabdallah, Krimo Nicolas-Virelizier, Emmanuelle Feugier, Pierre Morschhauser, Franck Delarue, Richard Farhat, Hassan Quittet, Philippe Berriolo-Riedinger, Alina Tempescul, Adrian Edeline, Véronique Maisonneuve, Hervé Fornecker, Luc-Matthieu Lamy, Thierry Delmer, Alain Dartigues, Peggy Martin, Laurent André, Marc[UCL] Mounier, Nicolas Traverse-Glehen, Alexandra Meignan, Michel (2019) The Lancet. Oncology — Vol. 20, no. 2, p. 202-2015 (2019)
    • Journal article
    Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
    Casasnovas, René-Olivier Bouabdallah, Reda Brice, Pauline Lazarovici, Julien Ghesquieres, Hervé Stamatoullas, Aspasia Dupuis, Jehan Gac, Anne-Claire Gastinne, Thomas Joly, Bertrand Bouabdallah, Krimo Nicolas-Virelizier, Emmanuelle Feugier, Pierre Morschhauser, Franck Sibon, David Bonnet, Christophe Berriolo-Riedinger, Alina Edeline, Véronique Parrens, Marie Damotte, Diane Coso, Diane André, Marc[UCL] Meignan, Michel Rossi, Cédric (2022) Journal of clinical oncology — Vol. 40, no. 10, p. 1091-1101 (2022)
    • Journal article
    Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
    Dupuis, Jehan Bachy, Emmanuel Morschhauser, Franck Cartron, Guillaume Fukuhara, Noriko Daguindau, Nicolas Casasnovas, René-Olivier Snauwaert, Sylvia Gressin, Remy Fox, Christopher P d'Amore, Francesco Annibale Staber, Philipp B Tournilhac, Olivier Bouabdallah, Krimo Thieblemont, Catherine André, Marc[UCL] Rai, Shinya Ennishi, Daisuke Gkasiamis, Argyrios Nishio, Mitsufumi Fornecker, Luc-Matthieu Delfau-Larue, Marie-Helene Sako, Nouhoum Mule, Sebastien de Leval, Laurence Gaulard, Philippe Tsukasaki, Kunihiro Lemonnier, François (2024) The Lancet. Haematology — Vol. 11, no.6, p. e406-e414 (2024)
    • Journal article
    Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
    Bachy, Emmanuel Houot, Roch Feugier, Pierre Bouabdallah, Krimo Bouabdallah, Reda Virelizier, Emmanuelle Nicolas Maerevoet, Marie Fruchart, Christophe Snauwaert, Sylvia Le Gouill, Steven Marolleau, Jean-Pierre Molina, Lysiane Moluçon-Chabrot, Cécile Thieblemont, Catherine Tilly, Hervé Bijou, Fontanet Haioun, Corinne Van Den Neste, Eric[UCL] Fabiani, Bettina Meignan, Michel Cartron, Guillaume Salles, Gilles Casasnovas, Olivier Morschhauser, Franck (2022) Blood — Vol. 139, no. 15, p. 2338-2346 (2022)
    • Journal article
    Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
    Sutton, Laurent Chevret, Sylvie Tournilhac, Olivier Diviné, Marine Leblond, Véronique Corront, Bernadette Leprêtre, Stéphane Eghbali, Houchingue Van Den Neste, Eric Michallet, Mauricette Maloisel, Frédéric Bouabdallah, Krimo Decaudin, Didier Berthou, Christian Brice, Pauline Gonzalez, Hugo Chapiro, Elise Radford-Weiss, Isabelle Leporrier, Nathalie Maloum, Karim Nguyen-Khac, Florence Davi, Frédéric Lejeune, Julie Merle-Béral, Hélène Leporrier, Michel (2011) Blood — Vol. 117, no.23, p. 6109-6119 (2011)
    • Journal article
    Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
    Crochet, Gilles[UCL] Iacoboni, Gloria Couturier, Audrey Bachy, Emmanuel Iraola-Truchuelo, Josu Gastinne, Thomas Cartron, Guillaume Fradon, Tom Lesne, Bastien Kwon, Mi Gounot, Romain Martínez-Cibrian, Nuria Castilla-Llorente, Cristina Abrisqueta, Pau Guerreiro, Manuel Sarkozy, Clémentine Aspa-Cilleruelo, José María Camus, Vincent Guidez, Stéphanie Chauchet, Adrien Deconinck, Eric Bouabdallah, Krimo Bosch, Francesc Barba, Pere Morschhauser, Franck Houot, Roch (2024) Blood — (2024)
    • Journal article
    Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
    Fornecker, Luc-Matthieu Lazarovici, Julien Aurer, Igor Casasnovas, René-Olivier Gac, Anne-Claire Bonnet, Christophe Bouabdallah, Krimo Feugier, Pierre Specht, Lena Molina, Lysiane Touati, Mohamed Borel, Cécile Stamatoullas, Aspasia Nicolas-Virelizier, Emmanuelle Pascal, Laurent Lugtenburg, Pieternella Di Renzo, Nicola Vander Borght, Thierry[UCL] Traverse-Glehen, Alexandra Dartigues, Peggy Hutchings, Martin Versari, Annibale Meignan, Michel Federico, Massimo André, Marc[UCL] LYSA-FIL-EORTC Intergroup (2023) Journal of clinical oncology — Vol. 41, no. 2, p. 327-335 (2023)